XML 37 R27.htm IDEA: XBRL DOCUMENT v3.7.0.1
Net Loss Per Share (Tables)
 3 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
The following tables reconcile the components of the numerator and denominator included in the calculations of diluted loss per share:
 
Three Months Ended March 31,
 
2017
 
2016
Numerator
 
 
 
Net loss attributable to Inovio Pharmaceuticals, Inc.
$
(23,085,907
)
 
$
(8,042,820
)
Reflect adjustment for decrease in fair value of warrant liability
(116,477
)
 
—

Numerator for use in diluted loss per share
$
(23,202,384
)
 
$
(8,042,820
)
 
 
 
 
Denominator
 
 
 
Weighted average number of common shares outstanding
74,152,609

 
72,230,411

Effect of dilutive potential common shares
148,275

 
—

Denominator for use in diluted loss per share
74,300,884

 
72,230,411

 
 
 
 
Net loss per share, diluted
$
(0.31
)
 
$
(0.11
)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following table summarizes potential common shares that were excluded from the diluted net loss per share calculation because of their anti-dilutive effect for the three months ended March 31, 2017 and 2016:
 
 
Common Stock Equivalents
2017
 
2016
Options to purchase common stock
7,841,669

 
7,135,624

Warrants to purchase common stock
—

 
560,904

Restricted stock units
1,376,893

 
732,668

Convertible preferred stock
8,456

 
8,456

Total
9,227,018

 
8,437,652